1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-08-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 15028626 2024-08-01 2025-07-31 15028626 2025-07-31 15028626 2024-07-31 15028626 2023-07-25 2024-07-31 15028626 2024-07-31 15028626 2023-07-24 15028626 core:FurnitureFittings 2024-08-01 2025-07-31 15028626 bus:Director1 2024-08-01 2025-07-31 15028626 core:FurnitureFittings 2025-07-31 15028626 core:WithinOneYear 2025-07-31 15028626 core:WithinOneYear 2024-07-31 15028626 core:ShareCapital 2025-07-31 15028626 core:ShareCapital 2024-07-31 15028626 core:RetainedEarningsAccumulatedLosses 2025-07-31 15028626 core:RetainedEarningsAccumulatedLosses 2024-07-31 15028626 bus:SmallEntities 2024-08-01 2025-07-31 15028626 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 15028626 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 15028626 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15028626 bus:FullAccounts 2024-08-01 2025-07-31 15028626 core:ComputerEquipment 2024-08-01 2025-07-31
COMPANY REGISTRATION NUMBER: 15028626
Wego Medical UK Limited
Filleted Unaudited Financial Statements
31 July 2025
Wego Medical UK Limited
Statement of Financial Position
31 July 2025
2025
2024
Note
£
£
Fixed assets
Tangible assets
5
2,047
800
Current assets
Debtors
6
16,317
7,392
Cash at bank and in hand
70,723
208,642
--------
---------
87,040
216,034
Creditors: amounts falling due within one year
7
343,125
309,412
---------
---------
Net current liabilities
256,085
93,378
---------
--------
Total assets less current liabilities
( 254,038)
( 92,578)
Provisions
( 63,997)
---------
--------
Net liabilities
( 190,041)
( 92,578)
---------
--------
Capital and reserves
Called up share capital
950
950
Profit and loss account
( 190,991)
( 93,528)
---------
--------
Shareholders deficit
( 190,041)
( 92,578)
---------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Wego Medical UK Limited
Statement of Financial Position (continued)
31 July 2025
These financial statements were approved by the board of directors and authorised for issue on 6 July 2026 , and are signed on behalf of the board by:
Mr DS Thakkar
Director
Company registration number: 15028626
Wego Medical UK Limited
Notes to the Financial Statements
Year ended 31 July 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The Old Mill, 9 Soar Lane, Leicester, LE3 5DE.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets measured at fair value through profit or loss.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied, stated net of discounts and of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures and fittings
-
25% straight line
Equipment
-
25% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
5. Tangible assets
Fixtures and fittings
Equipment
Total
£
£
£
Cost
At 1 August 2024
1,067
1,067
Additions
2,018
2,018
-------
-------
-------
At 31 July 2025
2,018
1,067
3,085
-------
-------
-------
Depreciation
At 1 August 2024
267
267
Charge for the year
504
267
771
-------
-------
-------
At 31 July 2025
504
534
1,038
-------
-------
-------
Carrying amount
At 31 July 2025
1,514
533
2,047
-------
-------
-------
At 31 July 2024
800
800
-------
-------
-------
6. Debtors
2025
2024
£
£
Trade debtors
14,637
Other debtors
1,680
7,392
--------
-------
16,317
7,392
--------
-------
7. Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
2,823
304
Amounts owed to group undertakings and undertakings in which the company has a participating interest
200,190
200,190
Social security and other taxes
7,532
6,540
Other creditors
132,580
102,378
---------
---------
343,125
309,412
---------
---------
8. Going concern
The companies liabilities exceed its assets by £190,041 (2024: £92,578) as at the year end. The directors have stated that the company will continue to be supported by the parent company and therefore the company will continue on a going concern basis.
9. Related party transactions
The immediate parent company is Weigao Medical International Co., Ltd, a company incorporated in China. The registered office is No.1 Weigao Road, Hi Tech Zone, Weihai, Shandong, China. The ultimate parent company is Shandong Weigao Group Medical Polymer Company Limited, a company incorporated in China. The registered office is No.1 Weigao Road, Hi Tech Zone, Weihai, Shandong, China. The company were provided with an interest free loan repayable on demand from a company with a common director. The amount outstanding at 31 July 2025 was £31,000 (2024: £Nil)